Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

GeneFerm Biotechnology Co. Ltd. (1796) Financial Statements

GeneFerm Biotechnology Co. Ltd. Financial Overview

GeneFerm Biotechnology Co. Ltd.'s market cap is currently NT$1.14B. The company's EPS TTM is NT$0.41; its P/E ratio is 162.76; and it has a dividend yield of 2.50%. GeneFerm Biotechnology Co. Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 677.10MNT$ 521.16MNT$ 793.77MNT$ 633.96MNT$ 522.33M
Gross ProfitNT$ 190.80MNT$ 96.75MNT$ 286.35MNT$ 222.16MNT$ 192.65M
Operating IncomeNT$ 46.04MNT$ -35.49MNT$ 153.56MNT$ 113.31MNT$ 79.15M
EBITDANT$ 115.40MNT$ 56.34MNT$ 231.09MNT$ 163.34MNT$ 124.51M
Net IncomeNT$ 28.86MNT$ -22.53MNT$ 124.62MNT$ 93.45MNT$ 57.41M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 280.26MNT$ 122.45MNT$ 120.15MNT$ 100.69MNT$ 539.61M
Total AssetsNT$ 1.28BNT$ 1.15BNT$ 1.18BNT$ 1.19BNT$ 1.32B
Total DebtNT$ 324.23MNT$ 246.19MNT$ 127.44MNT$ 219.16MNT$ 464.70M
Net DebtNT$ 43.97MNT$ 123.74MNT$ 7.29MNT$ 118.47MNT$ -74.91M
Total LiabilitiesNT$ 464.00MNT$ 358.31MNT$ 282.54MNT$ 358.86MNT$ 569.22M
Stockholders' EquityNT$ 816.66MNT$ 788.18MNT$ 892.84MNT$ 830.77MNT$ 747.66M
Cash Flow
Free Cash FlowNT$ 75.89MNT$ -14.61MNT$ 118.91MNT$ -155.98MNT$ -33.37M
Operating Cash FlowNT$ 99.31MNT$ 8.09MNT$ 190.31MNT$ 122.43MNT$ 112.23M
Investing Cash FlowNT$ -22.59MNT$ -22.83MNT$ -70.62MNT$ -280.33MNT$ -145.25M
Financing Cash FlowNT$ 81.06MNT$ 16.38MNT$ -99.87MNT$ -281.79MNT$ 224.81M

Currency in TWD

GeneFerm Biotechnology Co. Ltd. Earnings and Revenue History

-500M0500M1B-10 %0 %10 %20 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

GeneFerm Biotechnology Co. Ltd. Liabilities to Assets

0500M1B1.5B0 %25 %50 %75 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

GeneFerm Biotechnology Co. Ltd. Cash Flow

-400M-200M0200M400M2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

GeneFerm Biotechnology Co. Ltd. Forecast EPS vs Actual EPS

-0.4-0.200.20.40.6Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >